Risk of Amputations Associated with SGLT2 Inhibitors Compared to DPP ‐4 Inhibitors: A Propensity‐Matched Cohort Study

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - July 4, 2018 Category: Endocrinology Authors: Sruthi Adimadhyam MS , Todd A. Lee Pharm D, PhD , Gregory S. Calip PharmD, MPH, PhD , Daphne E. Smith Marsh PharmD, CDE, BC ‐ADM , Brian T. Layden MD, PhD , Glen T. Schumock PharmD, MBA, PhD Source Type: research